Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Civil Penalties For Human Subject Violations Considered By Kennedy

Executive Summary

Legislation granting FDA the authority to levy civil monetary penalties against researchers and institutions violating federal human subjects protections could be introduced by Sen. Kennedy (D-Mass.) before the end of the year.

You may also be interested in...



GAO Financial Conflict Of Interest Report Planned For Mid-July

The General Accounting Office plans to issue a report on financial conflict of interest in clinical research in mid-July.

GAO Financial Conflict Of Interest Report Planned For Mid-July

The General Accounting Office plans to issue a report on financial conflict of interest in clinical research in mid-July.

FDA Clinical Site Inspections Should Look At Recruitment Tactics - IG Report

FDA clinical site inspections should focus on recruitment tactics as well as data integrity, the HHS Office of the Inspector General suggests in a report on clinical trial recruitment released June 12.

Related Content

UsernamePublicRestriction

Register

OM007466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel